- Home
- TCMD vs VERV Comparison
TCMD vs VERV Comparison
Compare TCMD & VERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCMD
- VERV
- Stock Information
- Founded
- TCMD 1995
- VERV 2018
- Country
- TCMD United States
- VERV United States
- Employees
- TCMD N/A
- VERV N/A
- Industry
- TCMD Medical/Dental Instruments
- VERV Medicinal Chemicals and Botanical Products
- Sector
- TCMD Health Care
- VERV Health Care
- Exchange
- TCMD Nasdaq
- VERV Nasdaq
- Market Cap
- TCMD 378.7M
- VERV 382.5M
- IPO Year
- TCMD 2016
- VERV 2021
- Fundamental
- Price
- TCMD $17.85
- VERV $4.85
- Analyst Decision
- TCMD Hold
- VERV Strong Buy
- Analyst Count
- TCMD 1
- VERV 4
- Target Price
- TCMD N/A
- VERV $25.75
- AVG Volume (30 Days)
- TCMD 310.3K
- VERV 1.6M
- Earning Date
- TCMD 11-04-2024
- VERV 11-05-2024
- Dividend Yield
- TCMD N/A
- VERV N/A
- EPS Growth
- TCMD N/A
- VERV N/A
- EPS
- TCMD 0.65
- VERV N/A
- Revenue
- TCMD $285,051,000.00
- VERV $24,396,000.00
- Revenue This Year
- TCMD $8.83
- VERV $84.66
- Revenue Next Year
- TCMD $9.86
- VERV N/A
- P/E Ratio
- TCMD $27.63
- VERV N/A
- Revenue Growth
- TCMD 5.31
- VERV 219.91
- 52 Week Low
- TCMD $11.12
- VERV $4.31
- 52 Week High
- TCMD $17.90
- VERV $19.34
- Technical
- Relative Strength Index (RSI)
- TCMD 71.41
- VERV 40.26
- Support Level
- TCMD $15.22
- VERV $4.44
- Resistance Level
- TCMD $16.20
- VERV $4.93
- Average True Range (ATR)
- TCMD 0.84
- VERV 0.48
- MACD
- TCMD 0.16
- VERV -0.18
- Stochastic Oscillator
- TCMD 99.01
- VERV 17.30
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
About VERV Verve Therapeutics Inc.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States.